<p>The Centre has decided to allow import of any Covid-19 vaccine that is approved by FDA and WHO.</p>.<p>NITI Aayog health expert also said that import license will be given within one to two days.</p>.<p>Meanwhile, the Centre on Thursday approved extending the gap between the two doses of the Covishield vaccine to 12-16 weeks following a recommendation from a government panel, and said it is a "science-based decision" taken with confidence that there will be no extra risk.</p>.<p>However, the National Technical Advisory Group on Immunisation (NTAGI) has suggested no change for the dosage interval for Covaxin, the Union health ministry said.</p>
<p>The Centre has decided to allow import of any Covid-19 vaccine that is approved by FDA and WHO.</p>.<p>NITI Aayog health expert also said that import license will be given within one to two days.</p>.<p>Meanwhile, the Centre on Thursday approved extending the gap between the two doses of the Covishield vaccine to 12-16 weeks following a recommendation from a government panel, and said it is a "science-based decision" taken with confidence that there will be no extra risk.</p>.<p>However, the National Technical Advisory Group on Immunisation (NTAGI) has suggested no change for the dosage interval for Covaxin, the Union health ministry said.</p>